Inflammation in Metabolic and Cardiovascular Disorders-Role of Oxidative Stress

Area of Science:

• Immunology
• Cardiology
• Metabolic Disorders

Background:

• Cardiovascular diseases (CVD) are the leading global cause of death.
• Inflammation and oxidative stress are key contributors to CVD progression, leading to hypertension, metabolic dysfunction, and tissue damage.
• Reactive oxygen species (ROS) production by immune cells plays a critical role in CVD pathogenesis.

Purpose of the Study:

• To investigate the role of immune cell activation and ROS production in metabolic and cardiovascular disorders.
• To explore the contribution of a dysregulated complement system to immune imbalance and tissue damage under oxidative stress.
• To examine hypothalamic oxidative stress modulation as a potential therapeutic strategy for type-2 diabetes and obesity.

Main Methods:

• Review of current scientific literature on oxidative stress, inflammation, and immune cell activation in CVD.
• Analysis of the interplay between immune mediators, cellular players, and ROS in disease progression.
• Discussion of therapeutic strategies targeting oxidative stress pathways.

Main Results:

• Immune cell activation and ROS production contribute significantly to the development of metabolic and cardiovascular disorders.
• A dysregulated complement system exacerbates immune imbalance and tissue damage in the presence of increased oxidative stress.
• Modulating hypothalamic oxidative stress shows promise for treating type-2 diabetes and obesity.

Conclusions:

• Oxidative stress is a central mechanism in CVD, involving immune cell dysfunction and complement system dysregulation.
• Targeting oxidative stress and immune pathways presents novel therapeutic opportunities for CVD and related metabolic conditions.
• Natural antioxidant strategies and interventions modulating hypothalamic oxidative stress warrant further investigation for CVD treatment.